vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Outdoor Holding Co (POWW). Click either name above to swap in a different company.
FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $13.4M, roughly 1.0× Outdoor Holding Co). Outdoor Holding Co runs the higher net margin — 16.7% vs -34.7%, a 51.4% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -54.1%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Vista Outdoor Inc. was an American designer, manufacturer, and marketer that operated in two segments: shooting sports and outdoor products. It was a "house of brands" with more than 40 labels and subsidiaries.
FENC vs POWW — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $13.4M |
| Net Profit | $-4.8M | $2.2M |
| Gross Margin | — | 87.1% |
| Operating Margin | -18.5% | 14.7% |
| Net Margin | -34.7% | 16.7% |
| Revenue YoY | 73.8% | -54.1% |
| Net Profit YoY | -141.1% | 108.5% |
| EPS (diluted) | $-0.17 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $13.4M | ||
| Q3 25 | $12.5M | $12.0M | ||
| Q2 25 | $9.7M | $11.9M | ||
| Q1 25 | $8.8M | $12.6M | ||
| Q4 24 | $7.9M | $12.5M | ||
| Q3 24 | $7.0M | $12.0M | ||
| Q2 24 | $7.3M | $12.3M | ||
| Q1 24 | $25.4M | $-50.7M |
| Q4 25 | $-4.8M | $2.2M | ||
| Q3 25 | $-638.0K | $1.4M | ||
| Q2 25 | $-3.2M | $-6.5M | ||
| Q1 25 | $-1.2M | $-77.5M | ||
| Q4 24 | $-2.0M | $-26.1M | ||
| Q3 24 | $-5.7M | $-12.4M | ||
| Q2 24 | $-5.6M | $-14.8M | ||
| Q1 24 | $12.8M | $-5.2M |
| Q4 25 | — | 87.1% | ||
| Q3 25 | — | 87.1% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 87.5% | ||
| Q4 24 | — | 87.4% | ||
| Q3 24 | — | 86.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | — |
| Q4 25 | -18.5% | 14.7% | ||
| Q3 25 | -1.5% | 5.9% | ||
| Q2 25 | -28.3% | -50.7% | ||
| Q1 25 | -9.2% | -213.6% | ||
| Q4 24 | -11.8% | -163.8% | ||
| Q3 24 | -74.6% | -50.3% | ||
| Q2 24 | -69.4% | -50.8% | ||
| Q1 24 | 54.2% | — |
| Q4 25 | -34.7% | 16.7% | ||
| Q3 25 | -5.1% | 11.7% | ||
| Q2 25 | -32.7% | -54.5% | ||
| Q1 25 | -13.3% | -614.5% | ||
| Q4 24 | -25.0% | -208.7% | ||
| Q3 24 | -82.2% | -103.7% | ||
| Q2 24 | -76.5% | -120.2% | ||
| Q1 24 | 50.6% | 10.3% |
| Q4 25 | $-0.17 | $0.01 | ||
| Q3 25 | $-0.02 | $0.01 | ||
| Q2 25 | $-0.11 | $-0.06 | ||
| Q1 25 | $-0.04 | $-0.67 | ||
| Q4 24 | $-0.02 | $-0.23 | ||
| Q3 24 | $-0.21 | $-0.11 | ||
| Q2 24 | $-0.20 | $-0.13 | ||
| Q1 24 | $0.41 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $69.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $237.3M |
| Total Assets | $70.6M | $271.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $69.9M | ||
| Q3 25 | $21.9M | $65.7M | ||
| Q2 25 | $18.7M | $63.4M | ||
| Q1 25 | $22.7M | $30.2M | ||
| Q4 24 | $26.6M | $31.9M | ||
| Q3 24 | $40.3M | $33.5M | ||
| Q2 24 | $43.1M | $50.8M | ||
| Q1 24 | $51.2M | $55.6M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $237.3M | ||
| Q3 25 | $-4.5M | $235.4M | ||
| Q2 25 | $-7.5M | $222.5M | ||
| Q1 25 | $-5.9M | $222.0M | ||
| Q4 24 | $-5.9M | $299.6M | ||
| Q3 24 | $-5.2M | $325.6M | ||
| Q2 24 | $-1.4M | $342.5M | ||
| Q1 24 | $3.0M | $358.0M |
| Q4 25 | $70.6M | $271.7M | ||
| Q3 25 | $49.3M | $270.3M | ||
| Q2 25 | $44.9M | $269.5M | ||
| Q1 25 | $46.4M | $297.3M | ||
| Q4 24 | $44.9M | $355.4M | ||
| Q3 24 | $58.9M | $368.9M | ||
| Q2 24 | $63.2M | $398.6M | ||
| Q1 24 | $69.2M | $403.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $5.7M |
| Free Cash FlowOCF − Capex | — | $5.0M |
| FCF MarginFCF / Revenue | — | 37.6% |
| Capex IntensityCapex / Revenue | — | 4.8% |
| Cash ConversionOCF / Net Profit | — | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $5.7M | ||
| Q3 25 | $1.5M | $3.2M | ||
| Q2 25 | $-3.7M | $-6.7M | ||
| Q1 25 | $-4.3M | $-1.5M | ||
| Q4 24 | $-1.5M | $1.3M | ||
| Q3 24 | $-2.2M | $-9.3M | ||
| Q2 24 | $-8.4M | $-547.5K | ||
| Q1 24 | $39.0M | $4.3M |
| Q4 25 | — | $5.0M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $-7.6M | ||
| Q1 25 | — | $-2.3M | ||
| Q4 24 | — | $720.3K | ||
| Q3 24 | — | $-10.6M | ||
| Q2 24 | — | $-1.3M | ||
| Q1 24 | — | $1.4M |
| Q4 25 | — | 37.6% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | — | -63.8% | ||
| Q1 25 | — | -18.6% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | -88.3% | ||
| Q2 24 | — | -11.0% | ||
| Q1 24 | — | -2.8% |
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.4% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | — | -5.7% |
| Q4 25 | — | 2.55× | ||
| Q3 25 | — | 2.29× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
